X

Oral Oncology

Oral Oncology
Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial

There has been increased interest in hypofractionated accelerated chemoradiation for head and neck cancer during the recent first peak of the COVID-19 pandemic.

Oral Oncology
12/13/2020
Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19

The impact of COVID-19 on patients with cancer is emerging, but data are urgently needed for HNC patients or survivors who are inherently high-risk for severe illness and...

Oral Oncology
11/06/2020
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.

The purpose of this retrospective case study is to identify potential prognostic biomarkers in patients with HNSCC including APE1...

Oral Oncology
12/01/2020
Number of nodal metastases and the American Joint Committee on cancer staging of head and neck cutaneous squamous cell carcinoma: A multicenter study.

This study aimed to determine if the number of nodal metastases is an independent predictor of survival in HNcSCC, whether it provides additional prognostic information to the...

Oral Oncology
12/01/2020
COVID-19 screening protocols for preoperative assessment of head and neck cancer patients candidate for elective surgery in the midst of the pandemic: a narrative review with comparison between two Italian institutions

This study examined how preoperative screening had a key role in planning elective surgical activity for head and neck cancer during the COVID-19 pandemic.

Oral Oncology
01/01/2021
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.

The purpose of this retrospective case study is to identify potential prognostic biomarkers in patients with HNSCC including APE1 , NRF2 and PPARGC1A, and SOD3 and DCN.

Oral Oncology
12/01/2020
Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study.

This study investigates whether local p16 screening, by immunohistochemistry, has high positive predictive value for HPV status in a good prognosis HPV positive...

Oral Oncology
11/01/2020
Number of nodal metastases and the American Joint Committee on cancer staging of head and neck cutaneous squamous cell carcinoma: A multicenter study.

This multicentre collaborative study of 1128 patients represents the largest reported cohort of patients with nodal metastases from HNcSCC.

Oral Oncology
12/01/2020
The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.

The purpose of this study is to determine the tumor genomic, immunologic expression, and risk factors of treatment outcomes for patients with double HNSCC and ESCC.

Oral Oncology
12/01/2020
Salvage surgery in head and neck cancer: External validation of predictors of disease-specific survival.

This study aimed to validate the proposal of Hamoir et al. to use three items to predict the outcomes of salvage surgery.

Oral Oncology
10/01/2020
Subscribe to Oral Oncology

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#6fc969
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#a60538
#49cde9
#c20fce
#d95d39